What is endometriosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Endometriosis: Definition and Clinical Implications

Endometriosis is an inflammatory disease process characterized by lesions of endometrial-like tissue outside the uterus that is associated with pelvic pain and/or infertility, affecting approximately 10% of women during their reproductive years. 1

Definition and Pathophysiology

  • Endometriosis is defined as endometrial-like tissue located outside of the endometrial cavity, associated with inflammation and fibrosis, on or extending below the peritoneal surface 1
  • The condition is characterized by chronic inflammation and affects an estimated 176 million women worldwide 1, 2
  • Deep endometriosis (DE) is defined as lesions extending deeper than 5 mm under the peritoneal surface or those involving or distorting bowel, bladder, ureter or vagina 1

Clinical Presentation

  • The clinical presentation is highly variable, ranging from asymptomatic to severe symptoms that significantly impact daily activities 1
  • Pelvic pain is the most common symptom (90% of cases), manifesting as: 1, 2
    • Dysmenorrhea (painful menstruation)
    • Dyspareunia (painful intercourse)
    • Dyschezia (painful bowel movements)
    • Dysuria (painful urination)
    • Nonmenstrual pelvic pain
  • Approximately 50% of patients with endometriosis experience infertility 1, 2
  • Diagnosis is often delayed by 5-12 years after symptom onset, with most women consulting 3 or more clinicians prior to diagnosis 2

Comprehensive Characterization

Endometriosis should be understood as a systemic disease rather than just a pelvic condition, with the following key characteristics: 1, 3

  • Multifactorial etiology including genetic factors with possible epigenetic influences 1
  • Environmental exposure effects 1
  • Pain syndrome elements beyond localized pelvic pain 1
  • Proliferative nature of the lesions 1
  • Hormone responsiveness (estrogen-dependence and progesterone resistance) 1, 3
  • Systemic effects including altered metabolism in liver and adipose tissue 3
  • Systemic inflammation 3
  • Altered gene expression in the brain causing pain sensitization and mood disorders 3

Diagnostic Approaches

  • Definitive diagnosis traditionally requires surgical visualization of lesions with histological verification 2, 4
  • However, a suspected clinical diagnosis can be made based on symptoms, physical examination findings, and imaging 2
  • Imaging modalities include: 1, 2
    • Transvaginal ultrasound (TVUS) - first-line imaging modality
    • Expanded protocol TVUS studies for identifying and mapping deep endometriosis
    • Magnetic resonance imaging (MRI) - particularly useful for deep endometriosis
  • Normal physical examination and imaging do not exclude the diagnosis 2

Treatment Options

  • First-line treatments for symptomatic premenopausal women not desiring immediate pregnancy include: 2, 5
    • Combined oral contraceptives
    • Progestin-only options
  • Surgical removal of lesions (usually laparoscopic) should be considered when: 2
    • First-line hormonal therapies are ineffective
    • Hormonal treatments are contraindicated
  • Second-line hormone therapies include GnRH agonists and antagonists 2
  • Third-line treatments include aromatase inhibitors 2
  • Hysterectomy with surgical removal of lesions may be considered when initial treatments are ineffective, though approximately 25% of patients still experience recurrent pain 2

Challenges and Pitfalls

  • Diagnosis is often delayed due to variable symptoms and nonspecific physical examination findings 1, 2
  • Approximately 11-19% of individuals have no pain reduction with hormonal medications 2
  • 25-34% experience recurrent pelvic pain within 12 months of discontinuing hormonal treatment 2
  • Current classification systems (r-ASRM, Enzian, EFI) have limitations in correlating with symptom severity and predicting treatment outcomes 1
  • Even after hysterectomy, approximately 25% of patients experience recurrent pelvic pain and 10% require additional surgery 2

Economic and Quality of Life Impact

  • Endometriosis substantially affects quality of life for women and their families 4
  • The economic burden is estimated at $69.4 billion annually, similar to other chronic diseases like type 2 diabetes, Crohn's disease, and rheumatoid arthritis 1, 4

Understanding endometriosis as a systemic inflammatory disease with manifestations beyond the pelvis is crucial for proper diagnosis and comprehensive treatment approaches that address the full spectrum of symptoms and improve quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Endometriosis: A Review.

JAMA, 2025

Research

Endometriosis.

Nature reviews. Disease primers, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.